Macrogenics (MGNX) Return on Capital Employed Growth (3y) (2016 - 2026)
Macrogenics (MGNX) Return on Capital Employed Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4,893.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2,416.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -3,782.00 |
| 10 | Macrogenics | 254.43 Mn | 187.92 Mn | - | -1,002.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,002.00 |
| Dec 31, 2025 | 3,113.00 |
| Sep 30, 2025 | 6,916.00 |
| Jun 30, 2025 | 7,350.00 |
| Mar 31, 2025 | 3,934.00 |
| Dec 31, 2024 | 1,686.00 |
| Sep 30, 2024 | -1,859.00 |
| Jun 30, 2024 | -8,197.00 |
| Mar 31, 2024 | -4,570.00 |
| Dec 31, 2023 | -2,373.00 |
| Sep 30, 2023 | 1,631.00 |
| Jun 30, 2023 | 3,309.00 |
| Mar 31, 2023 | 3,520.00 |
| Dec 31, 2022 | -236.00 |
| Sep 30, 2022 | -6,419.00 |
| Jun 30, 2022 | -6,261.00 |
| Mar 31, 2022 | -3,991.00 |
| Dec 31, 2021 | -982.00 |
| Sep 30, 2021 | -3,553.00 |
| Jun 30, 2021 | -2,392.00 |